12-Month Lobbying Summary - Consultant

Novavax Inc. / Chris Gray, Consultant

Registration Summary

Active - Last Updated: 2024-05-09

Who is lobbying?

Novavax Inc. (Address & client representative)

Received government funding or funding expected in current financial year

Business Relationships

Novavax Inc. is not a subsidiary of any other parent companies.
Novavax Inc. is not a coalition.

Beneficiaries of the Lobbying Activity

The activities of Novavax Inc. are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
Novavax Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

What is being lobbied?

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Economic Development, Health, Industry	Canada's Strategic Innovation Fund, led by Innovation, Science and Economic Development, with respect to ensuring that the life sciences sector is a focus of the government's post-COVID recovery plan.	Policies or Program
Health, Industry	Engagement with federal government officials regarding Innovation, Science and Economic Development Canada's plans for the Biomanufacturing and Life Sciences Strategy with a focus on the importance of vaccines for public health in Canada.	Policies or Program
Health, Industry	Policies regarding the availability of Novavax's COVID-19 vaccine throughout Canada.	Policies or Program

Subject matter details in previous versions

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Subject matters were not required to be associated with subject matter details when this content was submitted	Canada's Strategic Innovation Fund, led by Innovation, Science and Economic Development, with respect to ensuring that the life sciences sector is a focus of the government's post-COVID recovery plan.	Policies or Program
Subject matters were not required to be associated with subject matter details when this content was submitted	Engagement with federal government officials regarding Innovation, Science and Economic Development Canada's plans for the Biomanufacturing and Life Sciences Strategy with a focus on the importance of vaccines for public health in Canada.	Policies or Program
Subject matters were not required to be associated with subject matter details when this content was submitted	Policies regarding the availability of Novavax's COVID-19 vaccine throughout Canada.	Policies or Program

Subject matters in previous versions

Government Procurement
Health
Industry
Science and Technology

Who is being lobbied?

Government Institutions

Canada Economic Development for Quebec Regions
Canadian Institutes of Health Research (CIHR)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)
Prime Minister's Office (PMO)
Public Health Agency of Canada (PHAC)
Senate of Canada

Government institutions added through a communication report:

Employment and Social Development Canada (ESDC)
Public Services and Procurement Canada (PSPC)
Intergovernmental Affairs Secretariat (IGA)

Communication techniques

Communication techniques that have been used or are expected to be used in the course of the undertaking:

Grass-roots communication
Oral communication
Written communication
Arrange one or more meetings

Who is the lobbyist?

Chris Gray, Consultant (Business address and contact information)

Public offices held

Consulting Firm

3Sixty Public Affairs Inc. (Address & contact information)

Registration number: 872472-376389
View all registrations versions

Monthly Communication Reports

What oral and arranged communications have taken place?

What oral and arranged communications have taken place?
Date	DPOH, Position Title \| Government Institution	Subject Matters
2024-06-14	Elizabeth Wong, Policy Advisor \| Office of the Minister, Employment and Social Development Canada (ESDC)	Health
2024-03-07	Victor Kandasamy, Policy Advisor (Quebec) \| Minister's Office, Public Services and Procurement Canada (PSPC)	Government Procurement, Health
2024-03-07	Ophelia John, Policy Advisor \| Office of the Minister of Health , Health Canada (HC) Eshan Naik, Director of Policy \| Minister's office, Health Canada (HC)	Government Procurement, Health
2024-03-07	Yash Nanda, Policy Advisor Finance Canada (FIN)	Government Procurement, Health
2024-03-07	Laurel Chester, Director of Parliamentary Affairs Intergovernmental Affairs Secretariat (IGA)	Government Procurement, Health, Science and Technology
2023-11-29	Jean-Sebastien Bock, Deputy Chief of Staff and Director of Policy \| Office of the Minister of Health, Health Canada (HC) Mark Holland, Minister of Health Health Canada (HC) Ophelia John, Policy Advisor \| Office of the Minister of Health , Health Canada (HC)	Government Procurement, Health
2023-11-28	Robert Kitchen, Member of Parlilament House of Commons	Government Procurement, Health, Industry

View all monthly communication reports

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Constituency Office Manager House of Commons, Office of Roy Cullen, M.P.	March 2000 to July 2002	Not a designated office
Legislative Assistant House of Commons, Office of David Iftody, M.P.	February 1999 to March 2000	Not a designated office
Assistant House of Commons, Office of Jon Gerrard, Secretary of State, Science and Industry	February 1997 to June 1997	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

12-Month Lobbying Summary - Consultant

Novavax Inc. / Chris Gray, Consultant

Who is lobbying?

Novavax Inc. (Address & client representative)

Received government funding or funding expected in current financial year

Business Relationships

Beneficiaries of the Lobbying Activity

What is being lobbied?

Subject Matter Details

Subject matters in previous versions

Who is being lobbied?

Government Institutions

Government institutions added through a communication report:

Communication techniques

Who is the lobbyist?

Chris Gray, Consultant (Business address and contact information)

Consulting Firm

What oral and arranged communications have taken place?

12-Month Lobbying Summary - Consultant

Novavax Inc. / Chris Gray, Consultant

Novavax Inc. (Address & client representative)

Received government funding or funding expected in current financial year

Business Relationships

Beneficiaries of the Lobbying Activity

Subject Matter Details

Subject matters in previous versions

Government Institutions

Government institutions added through a communication report:

Communication techniques

Chris Gray, Consultant (Business address and contact information)

Consulting Firm

Novavax Inc. - Address & Client Representative

3Sixty Public Affairs Inc.